Introduction {#Sec1}
============

Mainly occurring in tropical Africa, chronic infection with the filarial nematode *Onchocerca volvulus* producing microfilariae (mf), which cause diseases of skin, lymph nodes and eyes (World Health Organization, [@CR42]). Individuals only harbouring non-productive female worms do not show signs of disease apart from the onchocercoma, which contains very few immune cells (Specht et al. [@CR38]; Wildenburg et al. [@CR41]). The disease depends on the presence of mf or dead adult worms and the severity varies with the mf load, the immune status of the patients, the geographic region and on co-infections, but probably not or not much on the strain of *O. volvulus*. The observation of the disease variation led to the notion of a spectrum of clinical and immunological forms (Brattig [@CR4]; Hoerauf and Brattig [@CR19]; Connor et al. [@CR13]; World Health Organization, [@CR42]). The most frequently observed polar form of the spectrum represents the immunosuppressed hyporeactive patients (synonymous generalised form) with high counts of adult worms and mf, which are not eliminated in untreated patients, whereas these individuals are able to eliminate up to 90% of the infective larvae. The other pole is represented by the only rarely observed hyperreactive patients (synonymous localised form, hyperergic form or sowda(h)) with very low loads of adult worms and mf, because the host eliminates the mf by generation of local and humoral immune responses. These patients are characterised by a strong local and systemic Th2-type biased immune reaction (Brattig [@CR4]; Hoerauf and Brattig [@CR19]) often causing severe disease. The large group of patients with intermediate forms between the two poles (Rubio de Krömer et al. [@CR35]) comprises recently infected children and immigrants into endemic areas and other not hyperreactive patients, living in hypoendemic areas with low loads of adult worms and mf. These patients are still able to kill the mf without treatment indicated by their repeated attacks of acute papular dermatitis showing damaged mf in the skin. They may be termed "reactive" in contrast to hypo- or hyperreactive. Patients with chronic infections may experience different forms during their life. Studying onchocercomas by immunohistology (e.g. Albiez et al. [@CR2]; Büttner et al. [@CR10]; Korten et al. [@CR23]), we observed a small group of hyperreactive patients who had developed ectopic secondary lymph follicles (SLF) in their onchocercomas with production of mf, which were killed in these nodules and the skin. The onchocercomas from hyperreactive patients with only one or two pairs of mf-producing worms present a much larger infiltration of immune cells than those with many worms from hyporeactive patients (Büttner and Racz [@CR8]).

SLF occur in all lymphatic organs as lymph nodes and spleen and they are frequently elicited by infections in the intestinal tract from the salivary glands to the large intestine, e.g. in *Helicobacter pylori* infections of the stomach (Mazzucchelli et al. [@CR30]). Ectopic SLF develop in other organs than the lymphatic system in autoimmune and infectious diseases. Examples for autoimmune conditions are the muscles in juvenile dermatomyositis (López de Padilla et al. [@CR27]) and rheumatoid synovitis (Shi et al. [@CR37]; Timmer et al. [@CR40]). An example for a bacterial infection is the SLF, which was observed in all cutaneous lesions excised from 106 patients with a proven *Borrelia burgdorferi* infection (Colli et al. [@CR12]). Occasionally, ectopic SLF are seen after application of viral and bacterial vaccines (Cerroni et al. [@CR11]; Maubec et al. [@CR29]). However, there are only rare reports of ectopic SLF in the subcutis and cutis due to helminth infections of human patients. Ratnatunga and de Witesundera ([@CR34]) briefly mention SLF observed in subcutaneous nodules from human patients with *Dirofilaria repens*. Here we describe the types of immune cells observed in ectopic SLF in onchocercomas from human patients with hyperreactive onchocerciasis and also several inflammation and immunoregulation markers such as TGF-beta, HLA-DR, alpha1-antichymotrypsin, histamine, IgE and IgG subclasses and compare the findings with those in nodules from hyporeactive patients (Korten et al. [@CR25]) and lymph nodes.

Materials and methods {#Sec2}
=====================

Patients {#Sec3}
--------

Previously described criteria were used in this study for the diagnosis of hyperreactivity (Albiez et al. [@CR2]; Büttner et al. [@CR9]; Korten et al. [@CR24]). Briefly, patients with a medical history lasting longer than a year complained of strong pruritus, presented with a chronic papular and often lichenified onchodermatitis, an onchocercoma confirmed by excision, large regional lymph nodes, a positive local Mazzotti test with fresh papules (Darge and Büttner [@CR14]), no or less than 10 mf in the skin snip and usually more than 10% eosinophils in the blood.

Patients with the hyperreactive form of onchocerciasis often suffer from severe skin disease. Therefore, these patients were offered courses of low diethylcarbamazine doses at the beginning of the study and later ivermectin treatment in the Liberia Research Unit of the BNI from 1982 to 1990 (Albiez et al. [@CR2]; Darge and Büttner [@CR14]; Erttmann, [@CR16]). Nodule carriers were also offered nodulectomies (Albiez et al. [@CR3]), which often improve or cure the symptoms of hyperreactive patients until new worms are acquired and become productive. Sixty-three onchocercomas from 49 hyperreactive patients were extirpated and examined using histology. Among these, SLF were found in seven nodules from seven female patients. The onchocercomas were used for this study together with one nodule from a German boy, who had acquired the infection in Cameroon (Table [1](#Tab1){ref-type="table"}). The patients had presented a moderate to severe disease at the time of nodulectomy or at least before the diethylcarbamazine treatment (for classification see Büttner et al. [@CR9]). The nodules with SLF were compared with onchocercomas and lymph nodes from other hyperreactive and also from hyporeactive and intermediate patients living in Liberia, Yemen and other countries. Table 1Characteristics of Liberian patients and one German boy with hyperreactive onchocerciasis whose onchocercomas contained ectopic secondary lymph folliclesPatient no.Sex, age (years)Duration of disease (years)No. of lymph nodes swollenNo. of nodules, siteMf/mg skinTopical Mazzotti reaction (degree)Eosinophils (number/µl; and %)Disease severityTreatment before nodulectomy1F, 7241, iliac crest0+++1,597; 22%ModerateDEC2F, 10111, iliac crest0.2++2,240; 26%ModerateDEC3F, 13223, trochanter4.6+2,278; 25%ModerateNone4F, 17303, trochanter0+2,522; 26%SevereNone5F, 18633, iliac crest0.5+++825; 21%ModerateNone6F, 221131, iliac crest0.9+++n. d.SevereNone7F, 27201, trochanter0+810; 12%MildDEC8M, 9231, iliac crest0+++n. d.ModerateIvermectin*F* female, *M* male, *DEC* diethylcarbamazine, *n. d.* not determined

Immunohistochemistry {#Sec4}
--------------------

Onchocercomas had been fixed in 4% buffered formaldehyde solution and the nodule of a German boy in 80% ethanol, embedded in paraffin and stained with haematoxylin and eosin, Giemsa and Movat stains. Dewaxed sections underwent antigen retrieval according to the advices of the manufacturers providing the primary antibody. For CD3, CD20 and CD57 staining the sections were pretreated by boiling in citrate solution at pH 6 and for CD35 in EDTA solution at pH 8. Monoclonal antibodies (mabs) were used to characterise most of the immune cells: CD68 for mature macrophages (clone PG-M1, 1:50), calprotectin for young macrophages (L1-protein, MRP8/MRP14, clone MAC387, 1:50), mast cell tryptase (clone AA1, 1:200), CD3 for all T cells (clone UCHT1, 1:400), CD20 for B cells (clone L26, 1:50), CD23 for the low-affinity IgE (epsilon) receptor FcεR-II, clone MHM6, 1:30), CD45RO for a subset of activated T cells (clone UCHL1, 1:50, all previous antibodies from DakoCytomation, Hamburg, Germany), MHC class II molecule HLA-DR (clone TAL.1B5, 1:30, R&D Systems, Wiesbaden, Germany), defensin for neutrophils (1:4,000, Dianova, Hamburg, Germany), eosinophil cationic protein for eosinophils (ECP EG2, 1:50, Kabi Pharmacia, Uppsala, Sweden), CD57 for natural killer and some T cells (clone HNK-1, 1:20, Becton Dickinson, USA), CD35 for follicular dendritic cells (FDCs, clone RLB25, 1:60, Novocastra, Newcastle upon Tyne, UK), IgG1 (clone HP-6001, 1:200, Sigma, Deisenhofen, Germany), IgG2 (clone HP-6002, 1:200, Sigma) and IgG4 (clone HP-6025, 1:1,000, Sigma). We applied polyclonal antibodies (pabs) from rabbits against: *Dirofilaria immitis Wolbachia* surface protein to demonstrate *Wolbachia* endobacteria (*Di*WSP, 1:1000, from Prof. Claudio Bandi, Università degli Studi di Milano, Milano), alpha1-antichymotrypsin (1:500; DakoCytomation), IgE (1:2,000, DakoCytomation), IgA (1:10,000, Sigma), cathepsin G for neutrophils (1:50, ICN, Biomedicals, Mannheim, Germany) and histamine (1:250, Chemicon, Temecula, USA). For most mabs and the pabs the alkaline phosphatase-anti-alkaline phosphatase technique and for histamine the peroxidase-anti-peroxidase complex were applied according to the protocols from DakoCytomation. For CD3 and CD35 amino-9-ethylcarbazole (AEC) kits were used (PolyLink, Peroxydase Label horseradish peroxides (HRP), DCS Innovative Diagnostik Systeme, Hamburg, Germany). Not all sections from the nodules were stained with the differentiation markers mentioned above. For labelling the multifunctional cytokine TGF-beta sections from formaldehyde-fixed nodules were incubated with pabs produced in goats immunised with CHO cell-derived, recombinant human TGF-beta 1 latency-associated peptide (1:200, R&D Systems). A pre-diluted biotinylated anti-goat mouse mab served as secondary antibody and for visualisation, incubation with streptavidin--HRP and developing with the brown chromogenic substrate AEC were used (HRP-AEC Cell & Tissue Staining Kit, R&D Systems).

Results {#Sec5}
=======

The nodules were onchocercomas {#Sec6}
------------------------------

The eight nodules with SLF were all onchocercomas and not lymph nodes. They had been excised from the iliac crest or trochanter (Table [1](#Tab1){ref-type="table"}), contained one or two pairs of adult *O. volvulus*, were enclosed by a fibrous pseudocapsule, blood vessels entered the nodule from all sides and not from a hilus, they possessed no trabeculae, no subcapsular and intermediate sinuses and no typical medulla. We never observed adult *O. volvulus* in lymph nodes. All adult worms harboured *Di*WSP-positive *Wolbachia* endobacteria.

The onchocercomas were typical for hyperreactive patients {#Sec7}
---------------------------------------------------------

The eight onchocercomas showed the characteristic features of nodules from hyperreactive patients. They were all large and the four of the eight nodules, which were weighed in Liberia, had weights of 1.7, 2.8, 4.1 and 4.6 g. In contrast, only 3% of 1,830 onchocercomas from hyporeactive patients in Liberia weighed more than 1.3 g (Albiez et al. [@CR3]). In the onchocercomas from hyperreactive patients a small zone with the worms was surrounded by an infiltrate much larger than in hyporeactive nodules (Figs. [1](#Fig1-5){ref-type="fig"} and [2](#Fig1-5){ref-type="fig"}). In these infiltrates several or many SLF occurred (Figs. [2](#Fig1-5){ref-type="fig"}, [3](#Fig1-5){ref-type="fig"}, [4](#Fig1-5){ref-type="fig"} and [5](#Fig1-5){ref-type="fig"}) presenting networks of IgE (Fig. [3](#Fig1-5){ref-type="fig"}) and HLA-DR (Fig. [4](#Fig1-5){ref-type="fig"}) in the germinal centre, with T lymphocytes adjacent to the mantle zone (Fig. [5](#Fig1-5){ref-type="fig"}) and many B cells. Sixty nodules from 36 other hyperreactive patients extirpated in Liberia and 14 nodules from five patients in Yemen showed multiple small infiltrations of lymphocytes but no SLF. Furthermore, we did not find any SLF in more than 1,000 nodules from hyporeactive patients, which we examined during several studies after we had observed the first SLF in onchocercomas from hyperreactive patients. Figs. 1--5Nodules with ectopic secondary lymph follicles from patients with hyperreactive onchocerciasis. *1* A typical hyperreactive onchocercoma from a 13-year-old girl with a small worm centre (*arrowhead*) surrounded by much nodule tissue. *2* A nodule from a 7-year-old girl showing much reactive tissue with many SLF (*arrows*) surrounding a small worm centre (*arrowhead*). Giemsa stain. *3*--*4* Consecutive sections from a nodule of a 9-year-old German boy with many SLF (*arrows*), in which IgE (*3*) and HLA-DR (*4*) are expressed in the germinal centre. *5* The same nodule as (*2*) with SLF showing CD3-positive T lymphocytes in the mantle zone (*arrows*). *Scale bar* 1 mm

Immune cells in secondary lymph follicles {#Sec8}
-----------------------------------------

The main cell types in the ectopic SLF were B lymphocytes (Fig. [9](#Fig6-16){ref-type="fig"}). Around and less so within the SLF, CD3-positive T cells were present (Figs. [5](#Fig1-5){ref-type="fig"} and [6](#Fig6-16){ref-type="fig"}), which were CD45RO-positive in the germinal centre (Fig. [7](#Fig6-16){ref-type="fig"}). A subset of CD57-positive T cells occurred in the germinal centre (Fig. [8](#Fig6-16){ref-type="fig"}) and some in the mantle zone. CD20-positive B cells predominated in the germinal centre and were also seen in the mantle zone (Fig. [9](#Fig6-16){ref-type="fig"}). We observed calprotectin-positive young macrophages in the infiltrate around the SLF but not in the germinal centre (Fig. [10](#Fig6-16){ref-type="fig"}). Mature CD68-positive macrophages were found dispersed in the germinal centre (Fig. [11](#Fig6-16){ref-type="fig"}) and several of them were tingible body macrophages phagocytosing degenerated cells (Fig. [12](#Fig6-16){ref-type="fig"}). Characteristic for SLF, CD35-positive FDCs formed a network in the germinal centre (Fig. [13](#Fig6-16){ref-type="fig"}). Mast cells positive for tryptase (Fig. [14](#Fig6-16){ref-type="fig"}) and IgE (not shown), eosinophils positive for eosinophilic cationic protein (Fig. [15](#Fig6-16){ref-type="fig"}), and neutrophils positive for defensin (Fig. [16](#Fig6-16){ref-type="fig"}) or cathepsin G (not shown) did not occur in the SLF or only in small numbers. However, these cells were frequently found in other zones of the onchocercomas, especially around blood vessels and dead mf. Figs. 6--16Identification of different cell types in hyperreactive onchocercomas with secondary lymph follicles using immunohistology. *6*--*7* CD3-positive (*6*) and CD45Ro-positive (*7*) T cells mainly in the mantle zone (*arrows*) and few in the germinal centre (*arrowheads*). *7* From a 10-year-old girl. *8* CD57-positive T cells (*arrowheads*) in the germinal centre. *9* CD20-positive B cells mainly in the germinal centre (*arrowhead*) and some in the mantle zone (*arrow*). *10* Calprotectin-positive young macrophages are seen around the SLF and in the mantle zone (*arrows*) whereas the germinal centre does not show these cells (*arrowhead*). *11* Mature CD68-positive macrophages in the germinal centre (*arrowheads*) in the nodule from a 9-year-old German boy. *12* Tingible body macrophages with phagocytosed leukocytes (*arrowhead*) in the germinal centre of the nodule from the boy. Movat stain. *13* CD35-positive FDCs form a network in the germinal centre (*arrowheads*) but are nearly absent in the mantle zone (*arrow*). *14*--*16* Tryptase-positive mast cells (*14*), eosinophil cationic protein-positive eosinophils (*15*) and few defensin-positive neutrophils (*16*) are seen in the mantle zone (*arrows*) but not in the germinal centre (*arrowheads*). *Scale bar* 40 and 10 µm for (*12*)Figs. 17--27Expression of TGF-beta, HLA-DR, alpha-1-antichymotrypsin and immunoglobulins in hyperreactive onchocercomas with secondary lymph follicles. *17*--*19* TGF-beta is only weakly expressed by lymphocytes in the germinal centre (*arrowheads* in *17*) and nearly not in the mantle zone (*arrow*) of an SLF, whereas lymphocytes around a blood vessel (*bv*) are moderately TGF-beta-positive (*arrow* in *18*) in the same nodule of a 27-year-old woman; most of them are probably CD3-positive T cells as a consecutive section shows (*arrow* in *19*). *20* Weakly TGF-beta-positive lymphocytes in the mantle zone (*arrow*) and the germinal centre (*arrowhead*) in the nodule of a 7-year-old girl. *21*--*22* Many HLA-DR-positive lymphocytes in the germinal centre (*arrowheads*) and in the mantle zone and few positive macrophages in the mantle zone (*arrow* in *21*) in the nodule of a 7-year-old girl. *23*--*24* alpha1-antichymotrypsin is only weakly expressed in macrophages in the SLF (*arrowhead* in *23*) but strongly near to a vital female filaria (*arrows* in *24*). *25* A network of FDCs expressing IgE in the germinal centre (*arrowheads*) whereas the mantle zone is negative (*arrow*). *26* CD23-positive low-affinity IgE (epsilon) receptors are labelled in the germinal centre (*arrowheads*) in a section consecutive to (*3*). The mantle zone is negative (*arrow*). *27* Few IgG1-positive plasma cells in the mantle zone (*long arrow*), the germinal centre (*arrowhead*) and more near to the edge of the SLF (*short arrows*) in the nodule of a German boy. *Scale bar* 40 and 10 µm for (*22*)

Secondary lymph follicles expressed immunologically active compounds {#Sec9}
--------------------------------------------------------------------

The immunosuppressive cytokine TGF-beta was only weakly expressed by many lymphocytes and some macrophages in the SLF (Figs. [17](#Fig17-27){ref-type="fig"} and [20](#Fig17-27){ref-type="fig"}). Also in other zones of the onchocercomas around blood vessels lymphocytes expressed TGF-beta, among them probably CD3-positive T cells (compare Figs. [18](#Fig17-27){ref-type="fig"} and [19](#Fig17-27){ref-type="fig"}). In contrast to the weakly expressed TGF-beta, the antigen-presenting MHC class II molecule HLA-DR, which is expressed by B cells, macrophages and FDCs, formed a strong network in the germinal centre (Figs. [21](#Fig17-27){ref-type="fig"} and [22](#Fig17-27){ref-type="fig"}). The macrophages in the germinal centre only weakly expressed the acute-phase protein alpha1-antichymotrypsin (Fig. [23](#Fig17-27){ref-type="fig"}), whereas most neutrophils and some macrophages adjacent to adult worms and to degenerated mf were strongly labelled (Fig. [24](#Fig17-27){ref-type="fig"}). Most lymphocytes and macrophages in the SLF did not express histamine (Online Resource ESM[1](#MOESM1){ref-type=""}) but these cells were strongly histamine-positive adjacent to damaged mf (ESM[2](#MOESM1){ref-type=""}). Scattered plasma cells produced IgE in the mantle zone (not shown). In the germinal centre, IgE-positive FDCs formed a characteristic network (Figs. [3](#Fig1-5){ref-type="fig"} and [25](#Fig17-27){ref-type="fig"}), which corresponded to the expression of CD23, the low-affinity IgE (epsilon) receptor (Fig. [26](#Fig17-27){ref-type="fig"}). Only few plasma cells produced IgG1 (Fig. [27](#Fig17-27){ref-type="fig"}), IgG2 (ESM[3](#MOESM2){ref-type=""}) or IgG4 (ESM[4](#MOESM2){ref-type=""}) in the SLF. IgG1 was more produced in other zones of the hyperreactive nodule, where it was attached to the cuticle of degenerated mf (ESM[5](#MOESM2){ref-type=""}). On the other hand, many plasma cells produced IgG4 (ESM[6](#MOESM2){ref-type=""}) in onchocercomas from hyporeactive patients. IgA expression by few plasma cells was observed in some lymphocyte infiltrations (not shown).

We know that microfilaricidal treatment has an influence not only on the clinical features but also on the occurrence of immune cells in the nodules. But our diethylcarbamazine-treated patients only came back after some months when new mf or new adult worms had appeared. We did not observe differences regarding the immune cells in the SLF between treated and untreated patients (not shown).

Discussion {#Sec10}
==========

Hyperreactive onchocerciasis is rare, probably less than 1% of the infected individuals, and we only detected SLF in seven of 63 (12%) hyperreactive onchocercomas and none in hyporeactive nodules in Liberia. Can factors be identified which may contribute to the development of hyperreactivity and SLF formation? There is no indication that the filaria presents such a factor. For the hyperreactive patients in Yemen it was previously suggested that *Onchocerca* species other than *O. volvulus* might cause hyperreactivity. All filariae in our hyperreactive nodules, including those with SLF, from Yemen, Liberia and Ghana were morphologically *O. volvulus*, which we can differentiate from seven other *Onchocerca* species that we have examined by histology. DNA analysis of filariae from patients with hyperreactive onchocerciasis in Yemen, however, confirmed the diagnosis *O. volvulus* (Peter Fischer, Washington University, St. Louis, USA; personal communication). Furthermore, in the endemic area in Liberia so far no other *Onchocerca* species have been observed. Genetically different "strains" of *O. volvulus* occur usually in different geographic regions, whereas hyperreactive onchocerciasis occurs in Yemen, Sudan, Uganda, Liberia, Ghana, Benin, Guinea, Guatemala and probably other countries. Therefore host factors appear more probable. The dominance of the female gender in Liberia was obvious. The seven patients with SLF were all girls or women and 50 of 68 (74%) Liberian and 31 of 39 (79%) Ghanaian patients with hyperreactive onchocerciasis were female. But this may indicate rather cultural habits than biological causes since in Yemen, the men dominated with 43 of 54 (80%) hyperreactive patients. So far the most probable differences observed concern genes associated with immunologically active components such as the HLA-DR molecules (Meyer et al. [@CR31]) and a specific SNP Arg110Gln variant in the *IL-13* gene (Hoerauf et al. [@CR20]) known to lead to higher Th2 signalling, but other genetic factors associated with induction of the stronger Th2-dependent inflammation seen in sowda may still remain to be found. In contrast, hyporeactivity mainly depends on the high worm load.

The results from the eight examined nodules matched the histological findings described for onchocercomas from hyperreactive patients in Yemen and Liberia (e.g. Büttner and Racz [@CR8]; Connor et al. [@CR13]) and they were also in agreement with the rather few published immunohistological results (e.g. Brattig et al. [@CR7]; Korten et al. [@CR23]; Korten et al. [@CR24]). Exceptions were the SLF in these onchocercomas, as we found these structures only in the regional lymph nodes of onchocerciasis patients (Knab et al. [@CR22]; Racz et al. [@CR33]). The SLF are a characteristic component of the lymph nodes presenting features typical for the different forms of onchocerciasis.

Regional and especially femoral lymph nodes from hyperreactive patients are enlarged with diameters of 5 cm and more. They show extensive hyperplasia of the follicles (Abdel-Hameed et al. [@CR1]; Connor et al. [@CR13]; Racz et al. [@CR33]) and the germinal centres present a network of IgE-trapping FDCs. No or only few mf are seen in the lymph nodes from untreated hyperreactive patients because most of the mf have already been eliminated in onchocercomas or skin. In contrast, patients with longstanding hyporeactive infections increasingly develop fibrotic lymph nodes with finally only few small SLF (Gibson and Connor [@CR18]; Knab et al. [@CR22]; Racz et al [@CR33]). The SLF in regional lymph nodes from patients with intermediate forms are neither reduced by fibrosis nor do they show an extensive hyperplasia.

The immune cell populations in the ectopic SLF equalled those in onchocerciasis lymph nodes and often also those in other ectopic locations. The young calprotectin-positive macrophages occurred outside of the SLF and in the outer mantle zone. Calprotectin is an endogenous Toll-like receptor 4 agonist, playing a role during amplification of inflammation (Ehrchen et al. [@CR15]). In contrast, the CD68-positive mature macrophages were present in the germinal centre and some of them were tingible body macrophages indicating apoptosis and subsequent phagocytosis of activated cells. Such activated cells may be centrocytes (B cells) in the germinal centres, which interact with antigen held by FDCs and undergo high death rates in the SLF (MacLennan [@CR28]). Mast cells were also present in the mantle zone of the SLF as in onchocercal lymphadenitis (Racz et al. [@CR33]). Otherwise mast cells are rarely described in ectopic SLF, e.g. in rheumatoid arthritis (Timmer et al. [@CR40]). Since they were located outside the germinal centres in the T-cell-rich zones of the SLF and primarily influence the Th1/2 axis, we assume a Th2-driving, IgE-mediated function here as already stated for hyperreactive onchocercomas (Korten et al. [@CR23]). This is in line with the occurrence of eosinophils around and in the mantle zone and in other zones of onchocercomas with mf-producing worms (Wildenburg et al. [@CR41]) or dead filariae. Neutrophils were nearly absent in the SLF but they were abundant near older female worms, in the pseudocysts with male filariae and attached to dead mf in accordance with previous studies (Korten et al. [@CR23]). The neutrophils are attracted by compounds from the *Wolbachia* endobacteria harboured by the filariae (Brattig et al. [@CR6]), which do not occur in the SLF.

The predominance of B lymphocytes in the SLF corresponds to the strong antibody responses documented for the hyperreactive onchocerciasis (Brattig [@CR4]; Brattig et al. [@CR5]; Büttner et al. [@CR9]; Gallin et al. [@CR17]; Mpagi et al. [@CR32]). The characteristic IgE network of FDCs expressing the low-affinity IgE (epsilon) receptor correlated well to the IgE presence in onchocercomas, lymph nodes and peripheral blood and represents a key feature of hyperreactive onchocerciasis (Racz et al. [@CR33]; Timmann et al. [@CR39]). The IgE antibodies mainly refer to polyclonal IgE and in addition to *Onchocerca* protein-specific IgE (Mpagi et al. [@CR32]). No intracytoplasmatic expression of IgG subclasses was observed in the SLF although two subclasses are present in high concentrations in sera from hyperreactive patients (Brattig et al. [@CR5]). They are produced in other zones of the onchocercomas and in lymph nodes, more IgG1 and IgG3 by hyperreactive patients and more IgG4 by hyporeactive patients with high mf loads. It is known that IgG4 is preferably induced by regulatory T cell responses (Satoguina et al., [@CR36]).

The formation of ectopic SLF may contribute to the pathogenesis of hyperreactive onchocerciasis, e.g. the strong humoral response (Brattig [@CR4]; Büttner et al. [@CR9]) and the extended cellular infiltrates characteristic for hyperreactive onchocercomas, skin and lymph nodes (Büttner and Racz [@CR8]; Connor et al. [@CR13]; Racz et al. [@CR33]). An increase of cellular infiltration is also reported for rheumatoid arthritis (Timmer et al. [@CR40]). One potential role of ectopic SLF is to expand inflammation or defence locally, often associated with an exacerbated state of autoimmune disease (López De Padilla et al. [@CR27]).

SLF increase the probability that antigens encounter specific lymphocyte subsets. If the immune system is not able to create an efficient response against local antigens, it is an advantage to produce an SLF at the site of infection. The factors contributing to the generation of ectopic SLF induce a chronic stimulation of the immune system involving antibody-producing cells. There are other similarities between SLF in onchocercomas from hyperreactive patients reported here and the observations in other diseases. The B cell attracting chemokine-1 (CXCL13), a ligand of CXCR-5, is a major inductor for the formation of germinal centres in the synovium of chronic arthritis (Shi et al. [@CR37]) leading to high antibody production including autoantibody formation, which is also characteristic for hyperreactive onchocerciasis as autoantibodies against defensin show (Gallin et al. [@CR17]).

The expression of immunosuppressive TGF-beta, the proinflammatory tumour necrosis factor-alpha (TNF-alpha) and compounds such as alpha1-antichymotrypsin, histamine and HLA-DR varied in the ectopic SLF in onchocercomas and it differed from that in lymph nodes from hyporeactive patients (Knab et al. [@CR22]; Korten et al. [@CR24]). Since TGF-beta suppresses other immune cells, also in helminth infections (Ince et al. [@CR21]), its low expression in the SLF here corresponds with the hyperreactive status as in other onchocercal tissues in skin and lymph nodes of hyperreactive patients in contrast to strong TGF-beta expression in these tissues from hyporeactive patients (Brattig et al. [@CR7]; Korten et al. [@CR24], [@CR25]).

Alpha1-antichymotrypsin was produced in macrophages adjacent to the mf and adult worms but not in the SLF of the examined onchocercomas. This is in accordance with observations in lymph nodes from untreated and ivermectin-treated onchocerciasis patients (Knab et al. [@CR22]). The enzyme is a serine proteinase inhibitor, which can cleave cathepsin G that we observed in the neutrophils adjacent to adult worms and damaged mf. Thus it contributes to the protection of host tissues from damaging enzymes released by other host cells. Furthermore, the cells in the SLF did not produce histamine, which triggers local inflammatory reactions, and which we observed in the macrophages and lymphocytes near damaged mf as also previously reported for these cells and mast cells in nodules from hyperreactive patients (Korten et al. [@CR23]).

In contrast to the previous compounds, the HLA-DR complex was strongly expressed by B cells in the germinal centre and in macrophages and B cells adjacent to dead mf. Furthermore, lymphocytes and macrophages in and adjacent to the mantle zone and macrophages, giant cells and neutrophils near to a living productive female *O. volvulus* strongly expressed tumour necrosis factor-alpha in nodule tissues from our untreated patients 6 and 3 in Table [1](#Tab1){ref-type="table"} (ESM[7--8](#MOESM3){ref-type=""}; Hoerauf and Büttner, unpublished). TNF-alpha is a cytokine involved in systemic inflammation and participates in immune responses in SLF and the damaged neutrophils adjacent to the female worm may be related to the induction of cell death by TNF-alpha (Locksley et al. [@CR26]).

In conclusion, the ectopic SLF in onchocercomas from hyperreactive patients are equally composed as those in lymph nodes from onchocerciasis patients and they resemble SLF in other infectious and autoimmune diseases. The extensive expression of HLA-DR and IgE in conjunction with cytotoxic and phagocytosed cells in the germinal centre and Th2-directed cells in the mantle zone suggests that these ectopic SLF contribute to the strong local amplification of the Th2-biased immunopathology in the hyperreactive form of onchocerciasis, which is both, an infectious and an autoimmune disease. The weak expression of the immunosuppressive TGF-beta is in accordance with the hyperreactivity.
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